한글목차

배란 장애 진단의 동향과 예측

세계의 배란장애 진단시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 6.1%를 나타낼 전망이며, 2030년에는 8억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 계획 임신 채용 증가, 다양한 배란 장애에 대한 의식 증가, 출생률의 감소입니다. 세계의 배란장애 진단 시장의 미래는 병원, 부인과 클리닉, 진단센터 시장에서의 기회에 의해 유망시되고 있습니다.

배란장애 진단시장 인사이트

Lucintel의 예측에서 다낭성 난소 증후군은 2형 당뇨병 환자에서 PCOD 발병률 증가로 예측 기간 동안 가장 높은 성장이 예상됩니다.

이 시장에서 병원은 여전히 가장 큰 부문입니다.

북미는 첨단 건강 관리 인프라의 존재와 배란 장애 진단에 대한 일반 시민의 의식이 높아짐에 따라 예측 기간 동안 가장 높은 성장이 예상됩니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2.향후 성장이 가속되는 부문과 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&D가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 배란장애 진단 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 배란장애 진단 시장 동향(2018-2023년)과 예측(2024-2030년)
• 배란장애별 세계의 배란장애 진단 시장
  • 다낭성 난소 증후군
  • 고프로락틴혈증
  • 황체기 결손
  • 시상하부 기능장애
  • 종양
  • 자가면역성 난소염
  • 일차성 난소 부전증
  • 저항성 난소 증후군
  • 기타
• 진단별 세계의 배란장애 진단 시장
  • 호르몬의 임상 검사
  • 뇌하수체와 시상 하부의 CT 스캔과 MRI 스캔
  • 난소 생검
  • 기타
• 최종 용도별 세계의 배란장애 진단 시장
  • 병원
  • 부인과 클리닉
  • 진단센터
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 배란장애 진단 시장
• 북미의 배란장애 진단 시장
• 유럽의 배란장애 진단 시장
• 아시아태평양 배란장애 진단시장
• 기타 지역 배란 장애 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 배란장애별 세계의 배란장애 진단 시장의 성장 기회
  • 진단별 세계의 배란장애 진단 시장의 성장 기회
  • 최종 용도별 세계의 배란장애 진단 시장의 성장 기회
  • 지역별 세계의 배란장애 진단 시장의 성장 기회
• 세계의 배란장애 진단 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 배란장애 진단 시장의 능력 확대
  • 세계의 배란장애 진단시장에서의 합병, 인수, 합작사업
  • 인증 및 라이센스

제7장 유력 기업의 기업 프로파일

• Siemens Healthcare
• GE Healthcare
• Fujifilm Holdings
• Swiss Precision Diagnostics
• Toshiba Medical Systems
• Carestream Health
• Genova Diagnostics
• Quest Diagnostics
• LabCorp
• Esaote

영문목차

Ovulation Disorder Diagnosis Trends and Forecast

The future of the global ovulation disorder diagnosis market looks promising with opportunities in the hospital, gynecological clinic, and diagnostic center markets. The global ovulation disorder diagnosis market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are increasing adoption of planned pregnancies, growing awareness towards different ovulation disorders, and decrease in fertility rate.

A more than 150-page report is developed to help in your business decisions.

Ovulation Disorder Diagnosis by Segment

The study includes a forecast for the global ovulation disorder diagnosis by ovulation disorders, diagnosis, end use, and region.

Ovulation Disorder Diagnosis Market by Ovulation Disorders [Shipment Analysis by Value from 2018 to 2030]:

• Polycystic Ovarian Syndrome
• Hyperprolactinemia
• Luteal Phase Defect
• Hypothalamus Dysfunction
• Tumors
• Autoimmune Oophoritis
• Primary Ovarian Failure
• Resistant Ovary Syndrome
• Others

Ovulation Disorder Diagnosis Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

• Laboratory Testing of Hormones
• CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus
• Ovarian Biopsy
• Others

Ovulation Disorder Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Gynecological Clinics
• Diagnostic Centers
• Others

Ovulation Disorder Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Ovulation Disorder Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ovulation disorder diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ovulation disorder diagnosis companies profiled in this report include-

• Siemens Healthcare
• GE Healthcare
• Fujifilm Holdings
• Swiss Precision Diagnostics
• Toshiba Medical Systems
• Carestream Health
• Genova Diagnostics
• Quest Diagnostics
• Labcorp
• Esaote

Ovulation Disorder Diagnosis Market Insights

Lucintel forecasts that polycystic ovarian syndrome is expected to witness highest growth over the forecast period due to increasing incidence of PCOD in patients with type 2 diabetes.

Within this market, hospitals will remain the largest segment .

North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare infrastructure and growing awareness in public towards ovulation disorder diagnosis.

Features of the Global Ovulation Disorder Diagnosis Market

Market Size Estimates: Ovulation disorder diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ovulation disorder diagnosis market size by ovulation disorders, diagnosis, end use, and region. in terms of value ($B).

Regional Analysis: Ovulation disorder diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different ovulation disorders, diagnosis, end uses, and region.s for the ovulation disorder diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ovulation disorder diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the ovulation disorder diagnosis market size?

Answer: The global ovulation disorder diagnosis market is expected to reach an estimated $0.8 billion by 2030.

Q.2. What is the growth forecast for ovulation disorder diagnosis market?

Answer: The global ovulation disorder diagnosis market is expected to grow with a CAGR of 6.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the ovulation disorder diagnosis market?

Answer: The major drivers for this market are increasing adoption of planned pregnancies, growing awareness towards different ovulation disorders, and decrease in fertility rate.

Q.4. What are the major segments for ovulation disorder diagnosis market?

Answer: The future of the global ovulation disorder diagnosis market looks promising with opportunities in the hospital, gynecological clinic, and diagnostic center markets.

Q.5. Who are the key ovulation disorder diagnosis market companies?

Answer: Some of the key ovulation disorder diagnosis companies are as follows:

• Siemens Healthcare
• GE Healthcare
• Fujifilm Holdings
• Swiss Precision Diagnostics
• Toshiba Medical Systems
• Carestream Health
• Genova Diagnostics
• Quest Diagnostics
• LabCorp
• Esaote

Q.6. Which ovulation disorder diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that polycystic ovarian syndrome is expected to witness highest growth over the forecast period due to increasing incidence of PCOD in patients with type 2 diabetes.

Q.7. In ovulation disorder diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare infrastructure and growing awareness in public towards ovulation disorder diagnosis.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the ovulation disorder diagnosis market by ovulation disorders (polycystic ovarian syndrome, hyperprolactinemia, luteal phase defect, hypothalamus dysfunction, tumors, autoimmune oophoritis, primary ovarian failure, resistant ovary syndrome, and others), diagnosis (laboratory testing of hormones, CT scan & MRI scan of the pituitary gland & hypothalamus, ovarian biopsy, and others), end use (hospitals, gynecological clinics, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ovulation Disorder Diagnosis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Ovulation Disorder Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Ovulation Disorder Diagnosis Market by Ovulation Disorders
  • 3.3.1: Polycystic Ovarian Syndrome
  • 3.3.2: Hyperprolactinemia
  • 3.3.3: Luteal Phase Defect
  • 3.3.4: Hypothalamus Dysfunction
  • 3.3.5: Tumors
  • 3.3.6: Autoimmune Oophoritis
  • 3.3.7: Primary Ovarian Failure
  • 3.3.8: Resistant Ovary Syndrome
  • 3.3.9: Others
• 3.4: Global Ovulation Disorder Diagnosis Market by Diagnosis
  • 3.4.1: Laboratory Testing of Hormones
  • 3.4.2: CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus
  • 3.4.3: Ovarian Biopsy
  • 3.4.4: Others
• 3.5: Global Ovulation Disorder Diagnosis Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Gynecological Clinics
  • 3.5.3: Diagnostic Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Ovulation Disorder Diagnosis Market by Region
• 4.2: North American Ovulation Disorder Diagnosis Market
  • 4.2.2: North American Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
• 4.3: European Ovulation Disorder Diagnosis Market
  • 4.3.1: European Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
  • 4.3.2: European Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
• 4.4: APAC Ovulation Disorder Diagnosis Market
  • 4.4.1: APAC Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
  • 4.4.2: APAC Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
• 4.5: ROW Ovulation Disorder Diagnosis Market
  • 4.5.1: ROW Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
  • 4.5.2: ROW Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Ovulation Disorders
  • 6.1.2: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Diagnosis
  • 6.1.3: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by End Use
  • 6.1.4: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Region
• 6.2: Emerging Trends in the Global Ovulation Disorder Diagnosis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Ovulation Disorder Diagnosis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ovulation Disorder Diagnosis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Siemens Healthcare
• 7.2: GE Healthcare
• 7.3: Fujifilm Holdings
• 7.4: Swiss Precision Diagnostics
• 7.5: Toshiba Medical Systems
• 7.6: Carestream Health
• 7.7: Genova Diagnostics
• 7.8: Quest Diagnostics
• 7.9: LabCorp
• 7.10: Esaote